HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

PD-1 analysis on CD28(-) CD27(-) CD4 T cells allows stimulation-independent assessment of CMV viremic episodes in transplant recipients.

Abstract
Expression of the inhibitory receptor programmed death 1 (PD-1) on cytomegalovirus (CMV)-specific CD4 T cells defines a phenotype associated with CMV viremia in transplant recipients. Moreover, CD28(-) CD27(-) double negativity is known as a typical phenotype of CMV-specific CD4 T cells. Therefore, the co-expression of inhibitory receptors on CD28(-) CD27(-) CD4 T cells was assessed as a rapid, stimulation-independent parameter for monitoring CMV complications after transplantation. Ninety-three controls, 67 hemodialysis patients and 81 renal transplant recipients were recruited in a cross-sectional and longitudinal manner. CMV-specific CD4 T cell levels quantified after stimulation were compared to levels of CD28(-) CD27(-) CD4 T cells. PD-1 and cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) expression on CD28(-) CD27(-) CD4 T cells were related to viremia. A percentage of ≥0.44% CD28(-) CD27(-) CD4 T cells defined CMV seropositivity (93.3% sensitivity, 97.1% specificity), and their frequencies correlated strongly with CMV-specific CD4 T cell levels after stimulation (r = 0.73, p < 0.0001). Highest PD-1 expression levels on CD28(-) CD27(-) CD4 T cells were observed in patients with primary CMV viremia and reactivation (p < 0.0001), whereas CTLA-4 expression was only elevated during primary CMV viremia (p < 0.05). Longitudinal analysis showed a significant increase in PD-1 expression in relation to viremia (p < 0.001), whereas changes in nonviremic patients were nonsignificant. In conclusion, increased PD-1 expression on CD28(-) CD27(-) CD4 T cells correlates with CMV viremia in transplant recipients and may serve as a specific, stimulation-independent parameter to guide duration of antiviral therapy.
AuthorsJ Dirks, H Tas, T Schmidt, S Kirsch, B C Gärtner, U Sester, M Sester
JournalAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons (Am J Transplant) Vol. 13 Issue 12 Pg. 3132-41 (Dec 2013) ISSN: 1600-6143 [Electronic] United States
PMID24148296 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© Copyright 2013 The American Society of Transplantation and the American Society of Transplant Surgeons.
Chemical References
  • Antiviral Agents
  • CD28 Antigens
  • PDCD1 protein, human
  • Programmed Cell Death 1 Receptor
  • Tumor Necrosis Factor Receptor Superfamily, Member 7
Topics
  • Adult
  • Antiviral Agents (chemistry)
  • CD28 Antigens (metabolism)
  • CD4-Positive T-Lymphocytes (cytology)
  • Case-Control Studies
  • Cross-Sectional Studies
  • Cytomegalovirus
  • Cytomegalovirus Infections (complications)
  • Flow Cytometry
  • Humans
  • Kidney Transplantation
  • Middle Aged
  • Phenotype
  • Postoperative Complications
  • Programmed Cell Death 1 Receptor (metabolism)
  • Renal Dialysis
  • Renal Insufficiency (blood, complications, therapy)
  • Sensitivity and Specificity
  • Tumor Necrosis Factor Receptor Superfamily, Member 7 (metabolism)
  • Viremia (complications)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: